MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Validation of the Japanese version of the King’s Parkinson’s Disease Pain Scale and the King’s Parkinson’s Disease Pain Questionnaire

K. Kurihara, S. Zfujioka, T. Mishima, Y. Tsuboi (Fukuoka, Japan)

Meeting: 2023 International Congress

Abstract Number: 463

Keywords: Pain, Parkinson’s

Category: Parkinson's Disease: Non-Motor Symptoms

Objective: The purpose of this study is a validation of the Japanese version of the King’s Parkinson’s Disease Pain Scale (KPPS) and the King’s Parkinson’s Disease Pain Questionnaire (KPPQ).

Background: Pain is one of the common non-motor symptoms in patients with Parkinson’s disease (PD). The rater-based KPPS and the patient-based KPPQ were developed as scales to assess pain specific for PD patients. We have previously developed a Japanese version of the KPPS/KPPQ that retains linguistic validity. This time, we conducted a validation study to examine the reliability of the Japanese version of the KPPS/KPPQ.

Method: This study was conducted at six movement disorders centers in Japan. Age, sex, duration of disease, and levodopa-equivalent daily dose were extracted as basic patient information. Hoehn & Yahr (HY) stage and Movement Disorder Society-Unified Parkinson’s Disease Rating Scale were evaluated for the patients’ motor symptoms. The Japanese version of the KPPS/KPPQ and visual analog scales were used for evaluating pain. We used other scales including the Non-Motor Symptoms Scale (NMSS), Hospital Anxiety Depression Rating Scale, EuroQol 5 dimensions 3-level, Parkinson’s Disease Questionnaire-8 (PDQ-8), Parkinson’s disease sleep scale-version 2 (PDSS-2), 9-symptom Wearing-off Questionnaires. Internal consistency, construct validity, and test-retest reliability of the KPPS/KPPQ were investigated.

Results: A total of 146 PD patients with 48 males (32.9%), mean age of 68.2 ± 9.9 years, mean duration of disease 9.1 ± 5.1years, and mean HY stage 2.8 ± 0.9 were analyzed. The mean KPPS score was 21.1 ± 16.3. The most frequent pain types were musculoskeletal pain (82.9%). In the KPPS, the Cronbach’s α was 0.626 and the kappa coefficient for test-retest reliability was 0.552. In the KPPQ, the Cronbach’s α was 0.626 and the kappa coefficient for test-retest reliability was 0.593. Positive correlations were observed between total KPPS scores and the NMSS, PDQ-8, and PDSS-2. Positive correlations were also observed between the total KPPQ scores and the PDQ-8 and PDSS-2.

Conclusion: The internal consistency of the KPPS/KPPQ was questionable, and test-retest reliability was moderate. Positive correlations were found between the KPPS/KPPQ and other scales. The Japanese version of KPPS/KPPQ is useful tool for pain assessment in Japanese patients with PD.

To cite this abstract in AMA style:

K. Kurihara, S. Zfujioka, T. Mishima, Y. Tsuboi. Validation of the Japanese version of the King’s Parkinson’s Disease Pain Scale and the King’s Parkinson’s Disease Pain Questionnaire [abstract]. Mov Disord. 2023; 38 (suppl 1). https://www.mdsabstracts.org/abstract/validation-of-the-japanese-version-of-the-kings-parkinsons-disease-pain-scale-and-the-kings-parkinsons-disease-pain-questionnaire/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/validation-of-the-japanese-version-of-the-kings-parkinsons-disease-pain-scale-and-the-kings-parkinsons-disease-pain-questionnaire/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley